Search Within

Wungki Park

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (26)
  2. Journal Article (20)
  3. Editorial (1)
Groups
  1. CTCR Scholars (47)
  2. Center for Pancreatic Cancer Research (47)
  3. Department of Medicine (47)
  4. GSK Faculty (47)
  5. Gastrointestinal Oncology Service (47)
  6. Human Oncology and Pathogenesis Program (47)

More Groups

People
  1. Eileen O'Reilly (43)
  2. Anna Varghese (25)
  3. Vinod Balachandran (23)
  4. Joanne Chou (22)
  5. Kenneth Yu (22)
  6. William Jarnagin (22)

More People

Years
  1. 2025 (5)
  2. 2024 (17)
  3. 2023 (9)
  4. 2022 (6)
  5. 2021 (4)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (19)
  2. Annals of Surgical Oncology (5)
  3. JNCI: Journal of the National Cancer Institute (3)
  4. Nature (3)
  5. Annals of Oncology (2)
  6. Cancer (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (21)
  2. Oxford University Press (5)
  3. Springer (5)
  4. American Association for Cancer Research (4)
  5. Nature Publishing Group (4)
  6. Cell Press (2)

More Publishers

Results (47)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
    Journal Article

    Sethna, Z.; Guasp, P.; Reiche, C.; Milighetti, M.; Ceglia, N.; Patterson, E.; Lihm, J.; Payne, G.; Lyudovyk, O.; Rojas, L. A.; more...
    Nature (2025)

    Fulltext@MSK | Save
  • Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: Clinical insights and genomic features from a large contemporary cohort
    Journal Article

    Keane, F.; O’Connor, C.; Moss, D.; Chou, J. F.; Perry, M. A.; Crowley, F.; Saxena, P.; Chan, A.; Schoenfeld, J. D.; Singhal, A.; more...
    JNCI: Journal of the National Cancer Institute (2025)

    Fulltext@MSK | Save
  • Survival outcomes and genetic characteristics of resected pancreatic acinar cell carcinoma
    Journal Article

    Blair, A. B.; Radomski, S. N.; Chou, J.; Liu, M.; Howell, T. C.; Park, W.; O'Reilly, E. M.; Zheng, L.; Balachandran, V. P.; Wei, A. C.; more...
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • Clinical landscape of cell free DNA alterations in patients with advanced biliary tract cancer treated with targeted therapies
    Meeting Abstract

    Thummalapalli, R.; Darmofal, M.; Seier, K.; Khalil, D. N.; Walch, H. S.; Shia, J.; Park, W.; El Dika, I. H.; Chatila, W. K.; Schultz, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Molecular and clinical determinants of targeted therapy (TT) outcomes in biliary tract cancer (BTC): Analysis of a prospectively maintained next generation sequencing (NGS) biorepository
    Meeting Abstract

    Cowzer, D.; Walch, H. S.; Atri, P.; Shah, F.; Huq, R.; Khalil, D. N.; Park, W.; Yeh, R.; Do, R. K. G.; Basturk, O.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Phase II trial of Pembrolizumab and OLApaRib (POLAR) maintenance for select patients (pts) with metastatic pancreatic cancer (mPC) with (A) homologous recombination deficiency (HRD), (B) non-core HRD (ncHRD) and (C) exceptional response to platinum
    Meeting Abstract

    Park, W.; O'Connor, C.; Chou, J.; Schwartz, C.; Larsen, M.; Varghese, A.; Yu, K.; Balogun, F.; Yang, J.; Katz, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Automated real-world data integration improves cancer outcome prediction
    Journal Article

    Jee, J.; Fong, C.; Pichotta, K.; Tran, T. N.; Luthra, A.; Waters, M.; Fu, C.; Altoe, M.; Liu, S. Y.; Maron, S. B.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • EGFR-directed antibodies promote HER2 ADC internalization and efficacy
    Journal Article

    Gupta, A.; Michelini, F.; Shao, H.; Yeh, C.; Drago, J. Z.; Liu, D.; Rosiek, E.; Romin, Y.; Ghafourian, N.; Thyparambil, S.; more...
    Cell Reports Medicine (2024)

    Fulltext@MSK | Save
  • Salvage hepatic artery infusion chemotherapy after first-line systemic failure in patients with unresectable cholangiocarcinoma
    Meeting Abstract

    Nasar, N.; Armstrong, M.; Chou, J. F.; Gonen, M.; Soares, K.; Balachandran, V. P.; Drebin, J. A.; Kingham, T. P.; Wei, A. C. C.; D'Angelica, M. I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Extrahepatic cholangiocarcinoma: Genomic variables associated with anatomical location and outcome
    Meeting Abstract

    Preston, W. A.; Drill, E. N.; Boerner, T.; Harding, J. J.; Cercek, A.; O'Reilly, E. M.; Abou-Alfa, G. K.; Park, W.; Balachandran, V. P.; Drebin, J. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save